2016
DOI: 10.1021/acs.est.5b05311
|View full text |Cite
|
Sign up to set email alerts
|

Completing the Link between Exposure Science and Toxicology for Improved Environmental Health Decision Making: The Aggregate Exposure Pathway Framework

Abstract: Synopsis Driven by major scientific advances in analytical methods, biomonitoring, computational tools, and a newly articulated vision for a greater impact in public health, the field of exposure science is undergoing a rapid transition from a field of observation to a field of prediction. Deployment of an organizational and predictive framework for exposure science analogous to the “systems approaches” used in the biological sciences is a necessary step in this evolution. Here we propose the Aggregate Expos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
100
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 104 publications
(104 citation statements)
references
References 35 publications
2
100
0
Order By: Relevance
“…It may be relevant to exposure assessment, risk assessment, epidemiology, or all three. The target site exposure (the terminal outcome of the AEP), along with the molecular initiating event from the AOP, represent the point of integration between an AEP and an AOP' (Teeguarden et al, 2016). Antagonism…”
Section: Adverse Effectmentioning
confidence: 99%
“…It may be relevant to exposure assessment, risk assessment, epidemiology, or all three. The target site exposure (the terminal outcome of the AEP), along with the molecular initiating event from the AOP, represent the point of integration between an AEP and an AOP' (Teeguarden et al, 2016). Antagonism…”
Section: Adverse Effectmentioning
confidence: 99%
“…Another area of progress is the development of Aggregate Exposure Pathways which will provide information to derive models from. 104 There are a number of SAR approaches that can be used to screen out compounds that are not likely to reach the site of the MIE. Very commonly used (especially as a drug design tool) is the Lipinski Rule of 5 105 and various adaptions.…”
Section: Models For Exposure and Bioavailability -Adding Value To Aopsmentioning
confidence: 99%
“…Major challenges include how to integrate and interpret data in a meaningful way, how to account for shared exposures, how to integrate data across multiple spatial and temporal scales and methodological approaches, and how to account for measurement errors. The aggregate exposure pathway (AEP) framework, a conceptual framework that complements the adverse outcome pathways (AOP) concept, organizes exposure and toxicological data from source to dose and to outcome (97). Together, the two frameworks complete the view of the exposure-outcome continuum to enable knowledge integration and better understanding of the health impacts of chemical exposure.…”
Section: Data Analysis and Interpretationmentioning
confidence: 99%